Attached files
| file | filename |
|---|---|
| 10-Q - SPRING PHARMACEUTICAL GROUP, INC. | v230479_10q.htm |
| EX-31.2 - SPRING PHARMACEUTICAL GROUP, INC. | v230479_ex31-2.htm |
| EX-31.1 - SPRING PHARMACEUTICAL GROUP, INC. | v230479_ex31-1.htm |
EXHIBIT 32: Rule 13a-14(b) Certification
In connection with the Quarterly Report of China YCT International Group, Inc. (the “Company”) on Form 10-Q for the period ending December 31, 2010 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned, in the capacities and on the dates indicated below, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
June 16, 2011
|
/s/ Yan Tinghe
|
|
|
Yan Tinghe, Chief Executive Officer
|
||
|
June 16, 2011
|
/s/ Li Chuanmin
|
|
|
Li Chuanmin, Chief Financial Officer
|